Overview summary statement

Urology

Volumn 60, Issue 6, 2002, Pages 1-4

  Schaeffer, Anthony J ^a   Datta, Nand S ^b   Fowler, Jackson E ^c   Krieger, John N ^d   Litwin, Mark S ^e   Nadler, Robert B ^a   Nickel, J Curtis ^f   Pontari, Michel A ^g   Shoskes, Daniel A ^h   Zeitlin, Scott I ^e   Hart, Carol ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f QUEEN S UNIVERSITY   (Canada)

^g TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DEPARTMENT OF COLORECTAL SURGERY   (United States)

ⁱ InforMEDical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; CERNITIN; FINASTERIDE; PENTOSAN POLYSULFATE; QUERCETIN; ROFECOXIB; TERAZOSIN;

ANAMNESIS; BACTERIAL INFECTION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; HUMAN; INFLAMMATION; LEUKOCYTE; MEDICAL RESEARCH; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATITIS; REVIEW; SYMPOSIUM; URINALYSIS; URINE CULTURE;

BIOLOGICAL MARKERS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; GUIDELINES; HUMANS; INFECTION; LEUKOCYTE COUNT; MALE; PELVIC PAIN; PROSTATITIS;

EID: 0036993960     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01979-9     Document Type: Editorial

References (17)

1. Schaeffer A.J., Landis J.R., Knauss J.S., et al. Demographic and clinical characteristics of men with chronic prostatitis the NIH Chronic Prostatitis Cohort (CPC) Study. J Urol. 168:2002;593-598.
2. Litwin M.S. Measuring health related quality of life in men with prostate cancer. J Urol. 152:1994;1882-1887.
3. Krieger J.N., Nyberg L. Jr, Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA. 282:1999;236-237.
4. Schaeffer A.J., Knauss J.S., Landis J.R., et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis the NIH Chronic Prostatitis Cohort (CPC) Study. J Urol. 168:2002;1048-1053.
5. Ruggieri M.R., Braveraman A.S., Pontari M.A. Biochemical markers for inflammation and glands that contribute to the semen in patients with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 163:2000;26. [abstract].
6. Nadler R.B., Koch A.E., Calhoun E.A., et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 164:2000;214-218.
7. Hochreiter W.W., Nadler R.B., Koch A.E., et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 56:2000;1025-1029.
8. Shahed A.R., Shoskes D.A. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome correlation with gram positive bacterial growth and treatment response. J Androl. 21:2000;669-675.
9. Krieger J.N., Riley D.E., Vesella R.L., et al. Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol. 164:2000;1221-1228.
10. Nickel J.C., Downey J., Johnston B., et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome a prospective multicenter clinical trial. J Urol. 165:2001;1539-1544.
11. Nickel J.C., Gittleman M., Malek G., et al. Effect of rofecoxib in patients with chronic nonbacterial prostatitis a placebo controlled pilot study. J Urol. 165:2001;27. [abstract].
12. Nickel J.C., Forrest J., Tomera K.M., et al. Effects of pentosanpolysulfate sodium in men with chronic pelvic pain syndrome a multicenter randomized placebo controlled study. J Urol. 167:(suppl):2002;63. [abstract].
13. Downey J., Nickel J.C., Pontari M.A., et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome category IIIA CPPS (chronic nonbacterial prostatitis). J Urol. 167:(suppl):2002;26. [abstract].
14. Rugendorff E.W., Weidner W., Ebeling L., et al. Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol. 71:1993;433-438.
15. Shoskes D.A., Zeitlin S.I., Shahed A., et al. Quercetin in men with category III chronic prostatitis a preliminary prospective, double-blind, placebo-controlled trial. Urology. 54:1999;960-963.
16. Shoskes D. Use of the bioflavonoid quercetin in patients with long-standing chronic prostatitis. J Am Neutraceut Assoc. 2:1999;18-21.
17. Clemens J.Q., Nadler R.B., Schaeffer A.J., et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 56:2000;951-955.